Viridian Therapeutic (VRDN) PT Lowered to $20 at Wells Fargo

March 31, 2026 6:49 AM

Wells Fargo analyst Derek Archila lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $20.00 (from $29.00) while maintaining a Equal Weight rating.

No results found